HomeCompareBPMUF vs JEPI

BPMUF vs JEPI: Dividend Comparison 2026

BPMUF yields 2.82% · JEPI yields 8.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JEPI wins by $5.1K in total portfolio value
10 years
BPMUF
BPMUF
● Live price
2.82%
Share price
$71.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.9K
Annual income
$337.79
Full BPMUF calculator →
JEPI
JPMorgan Equity Premium Income ETF
● Live price
8.40%
Share price
$56.68
Annual div
$4.76
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$29.0K
Annual income
$1,528.62
Full JEPI calculator →

Portfolio growth — BPMUF vs JEPI

📍 JEPI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBPMUFJEPI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BPMUF + JEPI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BPMUF pays
JEPI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BPMUF
Annual income on $10K today (after 15% tax)
$239.44/yr
After 10yr DRIP, annual income (after tax)
$287.12/yr
JEPI
Annual income on $10K today (after 15% tax)
$714.16/yr
After 10yr DRIP, annual income (after tax)
$1,299.33/yr
At 15% tax rate, JEPI beats the other by $1,012.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BPMUF + JEPI for your $10,000?

BPMUF: 50%JEPI: 50%
100% JEPI50/50100% BPMUF
Portfolio after 10yr
$26.5K
Annual income
$933.21/yr
Blended yield
3.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BPMUF right now

BPMUF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
2.1
Piotroski
8/9
JEPI
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BPMUF buys
0
JEPI buys
0
No recent congressional trades found for BPMUF or JEPI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBPMUFJEPI
Forward yield2.82%8.40%
Annual dividend / share$2.00$4.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$23.9K$29.0K
Annual income after 10y$337.79$1,528.62
Total dividends collected$3.1K$11.7K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: BPMUF vs JEPI ($10,000, DRIP)

YearBPMUF PortfolioBPMUF Income/yrJEPI PortfolioJEPI Income/yrGap
1← crossover$10,982$281.69$11,260$840.19$278.00JEPI
2$12,040$289.11$12,641$907.94$601.00JEPI
3$13,178$296.22$14,150$978.20$972.00JEPI
4$14,404$303.03$15,795$1,050.85$1.4KJEPI
5$15,722$309.54$17,584$1,125.74$1.9KJEPI
6$17,138$315.76$19,526$1,202.74$2.4KJEPI
7$18,659$321.69$21,628$1,281.69$3.0KJEPI
8$20,293$327.33$23,898$1,362.43$3.6KJEPI
9$22,046$332.70$26,347$1,444.79$4.3KJEPI
10$23,927$337.79$28,982$1,528.62$5.1KJEPI

BPMUF vs JEPI: Complete Analysis 2026

BPMUFStock

Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. It offers Cresemba, an intravenous and oral azole antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union, as well as in Phase III clinical trials for invasive fungal infections in Japan. The company also provides Zevtera, an antibiotic for the treatment of community and hospital-acquired pneumonia, as well as in Phase III clinical trials for the treatment of acute bacterial skin and skin structure infections, and Staphylococcus aureus bacteremia. In addition, it engages in developing Derazantinib, a small molecule inhibitor, which is in phase 2 clinical trial for bile duct cancer, as well as in phase ½ clinical trial for bladder and stomach cancer; and Lisavanbulin, a tumor checkpoint controller drug. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Basel, Switzerland.

Full BPMUF Calculator →

JEPIETF

The fund seeks to provide the majority of the returns associated with its primary benchmark, the Standard & Poor's 500 Total Return Index (S&P 500 Index), while exposing investors to less risk through lower volatility and still offering incremental income. Under normal circumstances, the fund invests at least 80% of its assets in equity securities. It may also invest in other equity securities not included in the S&P 500 Index.

Full JEPI Calculator →
📬

Get this BPMUF vs JEPI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BPMUF vs SCHDBPMUF vs OBPMUF vs KOBPMUF vs MAINBPMUF vs JEPQBPMUF vs XYLDBPMUF vs DIVOBPMUF vs QYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.